Search Results
Results found for "Tack Kuntz"
- How GPCR Spatial Signaling Sparked a Scientific Journey
It was supposed to be just a summer project—routine pipetting, repetitive assays, a box to tick before Many GPCR scientists trace their origin story back to a single unexpected spark. Not a grand plan.
- Applications of Fluorescent Probes in Confocal Imaging of GPCRs: From Live to Fixed Cells
This technique can acquire three-dimensional image stacks, facilitating the reconstruction of GPCR distribution If the experiment is done on live cells , tracking real-time receptor internalization becomes possible
- Dynamic GPCR activation revealed through time-resolved Cryo-EM
With this high-resolution, dynamic view of GPCR activation, scientists can better tackle diseases by
- How Schild Analysis Protects Your Conclusions in GPCR Research
Welcome back GPCR Fans, Clean data can still mislead if the underlying assumptions aren’t tested.
- Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST2 and SST5...
quantification of SST2/SST5 dimerization in rat GH3 as well as in human melanoma cells either expressing (A7) or lacking
- Targeted Activation of G-Protein Coupled Receptor-Mediated Ca 2+ Signaling Drives Enhanced Cartilage
or pharmacological activation of endogenous Ca2+ signaling transducers; however, such approaches can lack
- Fluorescence Polarization in GPCR Research
We highlight this article by Tahk et al.
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
Welcome back GPCR fans, If your drug discovery strategy still relies on static GPCR models, you’re already
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
stall not because the target is wrong—but because the chemical matter interacting with that target lacks
- Predicting GPCR Function: Inside the Carlsson Lab’s Modeling Toolbox
To tackle these, the lab employs molecular docking, molecular dynamics simulations, and ligand-based
- The Five Traps of Ignoring Kinetics
And once you see it, you’ll never go back.
- Curve Shifts Don’t Lie, But Your Eyes Might
And once you make that shift, you’ll never go back.
- Understanding the Journey: Catherine Demery's Path to Addiction Science
It was mostly just because, I need to be back in the lab.”
- Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling
Using CRISPR-Cas9 knockout HEK cells lacking Gs proteins, a study by Stallaert et al. in 2017 showed
- 📰 GPCR Weekly News, May 1 to 7, 2023
Jack Antel to its clinical advisory board Crinetics Pharmaceuticals First Quarter 2023 Earnings: Revenues
- 📰 GPCR Weekly News, July 17 to July 23, 2023
Premium members can always go back and watch the recorded talks at any time. A corazonin G protein-coupled receptor gene in the tick Ixodes scapularis yields two splice variants,
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
Upcoming events: “Drug Discovery at Superluminal Speeds”; and Discovery on Target 2025—GPCR track you Expect practical guidance on TR-FRET compatibility, photobleaching resistance, and 3D stack acquisition druggability 🔹 The role of cryo-EM in capturing fully activated GPCR complexes 📅 Catch Aaron’s full talk at Discovery on Target, Sept 24–25 in Boston. 🎥 Plus, join us at the GPCR Track, GPCR Happy Hour, and
- The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think
With over 21,000 views and 7,785 downloads from Volume I, the Signal Transduction Research Topic is back
- 📰 GPCR Weekly News, June 5 to 11, 2023
Our website is updated as we confirm speakers so please check back often.
- 📰 GPCR Weekly News, February 13 to 19, 2023
From outside to inside and back again: the lysophosphatidic acid-CCN axis in signal transduction.
- 📰 GPCR Weekly News, September 18 to 24, 2023
If you couldn't make it, no sweat – our premium members can always go back and watch the recorded talks Short talk selections will be announced soon. Abstract submissions close on October 2nd.
- 📰 GPCR Weekly News, August 28 to September 3, 2023
You can submit your poster abstracts using this form and short talks will be selected from abstracts. pathophysiology and treatment of CNS disorders GPCRs in Oncology and Immunology From outside to inside and back
- 📰 GPCR Weekly News, February 26 to March 3, 2024
a resounding success; we have a waitlist for those eager to attend this course, which wil be coming back
- How Understanding Intracellular Drug Access Can Transform Your GPCR Drug Discovery Program
Welcome back GPCR fans, The pace of GPCR innovation is accelerating at a rate that can be difficult to
- 📰 Breaking Down the Latest GPCR Discoveries: a Weekly Update (Nov 27-Dec 3, 2023)
Deep Learning Dynamic Allostery of G-Protein-Coupled Receptors Industry News Sosei Heptares to take back In Parkinson’s Treatment GPCR Events, Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk
- 📰 GPCR Weekly News, November 20 to 26, 2023
with Multispan Cell Engineering and Assay Services $3bn sales potential for drug Sosei Heptares wants back Discovery and Development GPCR Events, Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk
- How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology
a cold email from a biologist he’d never met, asking if he could synthesize a molecule “when you’re back
- 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024
platform to connect from anywhere in the world And if you go for a Premium Membership , you'll not only back
- Harnessing Deep Mutational Scanning for Enhanced Drug Discovery
Additionally, DMS is not universally applicable to all proteins; it struggles with proteins that lack
- The Hidden Burn: How Internal Misalignment Drains Your Biotech’s Runway
You track the burn rate. You watch the runway shrink. You delay hires. We’re not talking about personality clashes or investor drama. 👉 We’re talking about the type of quiet This breeds passive execution, second-guessing, and a lack of ownership .


















